Facioscapulohumeral muscular dystrophy is a genetically acquired disease that leads to progressive muscle weakness and severely decreased functional capacity in affected individualsâ€”the understanding of how the interplay of epigenetic factors has evolved substantially in recent years. This activity reviews the current knowledge of the etiology and epidemiology of facioscapulohumeral muscular dystrophy. This activity outlines the evaluation and treatment of facioscapulohumeral muscular dystrophy and explains the role of the interprofessional team in improving the care of patients with this condition.

**Objectives:**
- Identify the etiology of facioscapulohumeral muscular dystrophy medical conditions and emergencies.
- Review the evaluation of facioscapulohumeral muscular dystrophy.
- Outline the management options available for facioscapulohumeral muscular dystrophy.
- Describe some interprofessional team strategies for improving care coordination and communication to advance facioscapulohumeral muscular dystrophy and improve outcomes.